These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 25881507)
1. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis. Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507 [TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome. Li X; Wan L; Geng J; Wu CL; Bai X J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249 [TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706 [TBL] [Abstract][Full Text] [Related]
4. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma. Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
7. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. Zhang Z; Guo Y Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417 [TBL] [Abstract][Full Text] [Related]
9. AP‑4 predicts poor prognosis in non‑small cell lung cancer. Gong H; Han S; Yao H; Zhao H; Wang Y Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973 [TBL] [Abstract][Full Text] [Related]
10. Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs). Pircher A; Fiegl M; Untergasser G; Heidegger I; Medinger M; Kern J; Hilbe W Lung Cancer; 2013 Aug; 81(2):252-8. PubMed ID: 23664449 [TBL] [Abstract][Full Text] [Related]
11. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC. Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740 [TBL] [Abstract][Full Text] [Related]
12. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284 [TBL] [Abstract][Full Text] [Related]
14. Characterization of periostin isoform pattern in non-small cell lung cancer. Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858 [TBL] [Abstract][Full Text] [Related]
15. Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer? Tachezy M; Zander H; Wolters-Eisfeld G; Müller J; Wicklein D; Gebauer F; Izbicki JR; Bockhorn M Stem Cells; 2014 Jun; 32(6):1429-36. PubMed ID: 24501004 [TBL] [Abstract][Full Text] [Related]
16. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Patel M; Lu L; Zander DS; Sreerama L; Coco D; Moreb JS Lung Cancer; 2008 Mar; 59(3):340-9. PubMed ID: 17920722 [TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related]
20. Expression of KISS1 and KISS1R (GPR54) may be used as favorable prognostic markers for patients with non-small cell lung cancer. Sun YB; Xu S Int J Oncol; 2013 Aug; 43(2):521-30. PubMed ID: 23716269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]